Grown Rogue International (GRUSF) EPS (Basic) Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) EPS (Basic) Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | -188.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -188.42% |
| Sep 30, 2025 | 408,607,113.45% |
| Jan 31, 2023 | 314.92% |
| Jan 31, 2022 | 74.28% |
| Jul 31, 2021 | 95.61% |
| Apr 30, 2021 | 32.64% |
| Jan 31, 2021 | 55.06% |
| Oct 31, 2020 | 100.99% |
| Jul 31, 2020 | 27.94% |
| Apr 30, 2020 | 38.30% |
| Jan 31, 2020 | 71.66% |
| Oct 31, 2019 | 60.83% |
| Jul 31, 2019 | 97.27% |
| Apr 30, 2019 | 85.26% |
| Jan 31, 2019 | 54.78% |
| Aug 31, 2018 | 103.77% |
| May 31, 2018 | 89,632,921.86% |
| Feb 28, 2018 | -7,225,128,987.47% |
| Nov 30, 2017 | 2,938,000,706.64% |
| Aug 31, 2017 | -28,913.58% |